BSL
AMGN icon

Blue Sparrow LLC’s Amgen AMGN Stock Holding History

Blue Sparrow LLC’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Sell
5,020
-27,392
-85% -$9.77M 0.03% 134
2025
Q4 		$10.6M Buy
+32,412
New +$10.3M 0.2% 65

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Blue Sparrow LLC's AMGN Position: Q1 2026 in Review

Blue Sparrow LLC reduced its Amgen (AMGN) stake by 85% in Q1 2026, selling an estimated $9.77M and leaving 5,020 shares worth $1.77M. The position accounts for 0.03% of the portfolio, ranked #134.

Blue Sparrow LLC first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $10.6M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Blue Sparrow LLC held 5,020 shares of Amgen worth $1.77M as of Q1 2026.
  • Blue Sparrow LLC sold 27,392 Amgen shares in Q1 2026, an estimated $9.77M.
  • Amgen made up 0.03% of Blue Sparrow LLC's portfolio in Q1 2026, its #134 holding.
  • Blue Sparrow LLC first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
  • Blue Sparrow LLC's Amgen position peaked at $10.6M in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Blue Sparrow LLC's 13F filing for Q1 2026, filed 15 May 2026.